Just a fraction of research funds into Alzheimer’s, heart disease, and autoimmune disease goes toward women, even though they disproportionately face those ailments.
That’s according to a new report from the group Women’s Health Access Matters, which found that a $300 million dollar investment into research focused on women would yield a $13 billion economic return in reduced healthcare costs, better quality of life, and years of productivity returned to the workforce.
